Research progress on CXC chemokines and their receptors and pul-monary fibrosis
10.12092/j.issn.1009-2501.2024.05.014
- VernacularTitle:CXC趋化因子及其受体与肺纤维化的研究进展
- Author:
Feng CHEN
1
;
Long LI
;
Jie WANG
;
Shengfei LIU
Author Information
1. 兰州大学第一临床医学院,兰州 730000,甘肃
- Keywords:
pulmonary fibrosis;
CXC chemokine;
CXC chemokine receptor
- From:
Chinese Journal of Clinical Pharmacology and Therapeutics
2024;29(5):583-589
- CountryChina
- Language:Chinese
-
Abstract:
Pulmonary fibrosis(PF)is a common,persistent,irreversible,fatal chronic lung disease with a median survival of 2-4 years after diagnosis.It is characterized by excessive extracellular matrix deposition and scarring in the lungs,leading to functional failure,severe respiratory problems and even death.Numerous studies have shown that CXC chemokines and their receptors play important roles in PF and other desmoplastic disorders.Sever-al studies have shown that chemokines may be-come new targets for the treatment of many dis-eases.Here,we review the role of key CXC chemo-kines and their receptors in PF to provide a refer-ence for the treatment of PF.
